↓ Skip to main content

A molecular signature in blood identifies early Parkinson’s disease

Overview of attention for article published in Molecular Neurodegeneration, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
6 X users
patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
116 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A molecular signature in blood identifies early Parkinson’s disease
Published in
Molecular Neurodegeneration, May 2012
DOI 10.1186/1750-1326-7-26
Pubmed ID
Authors

Leonid Molochnikov, Jose M Rabey, Evgenya Dobronevsky, Ubaldo Bonuccelli, Roberto Ceravolo, Daniela Frosini, Edna Grünblatt, Peter Riederer, Christian Jacob, Judith Aharon-Peretz, Yulia Bashenko, Moussa BH Youdim, Silvia A Mandel

Abstract

The search for biomarkers in Parkinson's disease (PD) is crucial to identify the disease early and monitor the effectiveness of neuroprotective therapies. We aim to assess whether a gene signature could be detected in blood from early/mild PD patients that could support the diagnosis of early PD, focusing on genes found particularly altered in the substantia nigra of sporadic PD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
Australia 1 <1%
Brazil 1 <1%
Unknown 111 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 22%
Student > Ph. D. Student 21 18%
Student > Master 12 10%
Professor > Associate Professor 8 7%
Student > Doctoral Student 6 5%
Other 23 20%
Unknown 21 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 17%
Biochemistry, Genetics and Molecular Biology 17 15%
Medicine and Dentistry 16 14%
Neuroscience 10 9%
Nursing and Health Professions 7 6%
Other 20 17%
Unknown 26 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2019.
All research outputs
#2,626,990
of 22,668,244 outputs
Outputs from Molecular Neurodegeneration
#335
of 842 outputs
Outputs of similar age
#17,974
of 165,202 outputs
Outputs of similar age from Molecular Neurodegeneration
#2
of 11 outputs
Altmetric has tracked 22,668,244 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,202 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.